Vagina Rejuvenation In Boston & Rhode Island Area

Vaginal Skin Tightening!

Vagina Tightening with Viveve II

Exilis Ultra 360 Yearly Maintenance Program

GET STARTED


The Vagina Rejuvenation  treatment is now available with 2 devicesViveve  II or  Exilis Ultra Femme 360™.

The procedure brings a whole new approach to women's health by  providing a solution to women's intimate issues. 

Internal laxity, Labia Minora tightening, Menopausal issues with dryness or painful intercourse (dyspareunia) are Vaginal Rejuvenation Solutions that improve both visual appearance and enhanced sexual intimacy.

4 Great Reasons for
Vaginal Rejuvenation Combination of Viveve with Exilis Ultra Femme 360

Easy Sessions - No Downtime or Pain

Painless and
No Downtime
- No Restrictions -
Resume normal activities

Non surgical, non-invasive approach to a pain free solution for the female rejuvenating the vaginal area.

It has one of the shortest radio frequency intimate procedures from start to finish- but it has the most power. There is no downtime.

All activities can be resumed that same day.

 Tightens Internal  or External Skin

Vaginal Canal,
Labia Minora and Majora Areas

Improving sexual intimacy is important to alot of woman. How it feels to both you and your spouse can effect your relationship. This treatment aids in increasing sexual sensation by tightening the internal vaginal canal so additional friction is increased. An optional external treatment for labia reduction can also be provided which improves visual appeal.

In order to maximize results, the Vagina Rejuvenation treatment wand provides 360 degrees of uniform heat throughout the entire canal maximizing safety, efficiency and efficacy.

Urinary Stress
Incontinence
and/or
PostMenopausal Dryness

Urinary Stress Incontinenceand Dryness is a commonplace condition that occurs most often post pregnancy or menopausal. 
Vaginal Rejuvenation helps with:
  • naturally increasing lubrication.
  • dyspareunia (pain with intercourse),
  • helps with mild to moderate urinary stress incontinence from coughing or sneezing

Great Results!
Vagina Rejuvenation
improvement
in as early
as 1 week

Viveve laser treatment is a ONE treatment protocol assuming no complex situations exist.

With the Exilis Ultra Femme 360 device, we recommend 3 sessions spaced one to two weeks apart.

Vagina Rejuvenation Results may be seen as early as a week and continues to improve over a 6-12 week period.

We suggest yearly maintenance treatments with Exilis Ultra 360 to maintain collagen levels.
Viginal Tightening Rejuvenation

How Does Vaginal Rejuvenation with Viveve or Exilis Femme 360 Work?

  • Vagina Rejuvenation is a non surgical treatment with radiofrequency delivery to both internal and/or external genitalia by a single applicator to tighten skin & vagina walls. The RF Energy causes skin contraction.
  • High satisfaction rating. More powerful than competing radio frequency devices on the market.
  • No Pain or Downtime and only short treatment time needed per intravaginal treatment.
Provides full 360 circumference vagina wall heating at tolerable temperatures compared to ablative lasers thus removing risk for infection or discharge. Various sizes applicators for different patients. Because every body is different.

Benefits of Vagina Rejuvenation
with Viveve or Exilis

Vagina Rejuvenation and entire vulva area including:
  • Plumping of Labia Majora.
  • Lifting and firming of Labia Minora.
  • Tightening of Introitus (vaginal opening).
  • Tightening of Vaginal Canal.
  • Tightening of Perinium
  • Increased Blood Flow to Clitoris.
  • Increased Sensitivity & Improved Orgasm.
  • Improvement in Stress Urinary Incontinence.
  • Improves dryness after cancer radiation/chemotherapy.
rocknrollArtboard 7

Be
Happy!

Ultra Femme 360 and Viveve Frequently Asked Questions:

Once again, our MedSpa's are the Pioneer in the Boston and Rhode Island area as one of the first to offer the Viveve II and Exilis Ultra 360 for non-invasive vagina technology for best in class results for stress-induced urinary incontinence, feminine dryness, atrophy, and improved sexual gratification.

WHAT IS VAGINA REJUVENATION WITH THE BTL ULTRA FEMME 360 or Viveve like?

Radio Frequency technology is a new solultion to improve women’s intimate well being. It treats vagina and vulva (except labia minora), non-invasively, without pain, and with a short treatment time.

HOW MANY BTL ULTRA FEMME VAGINA REJUVENATION TREATMENTS WILL I NEED?  What about Viveve?

The Viveve II is a 1 session only treatment in most cases.
The Exilis Ultra Femme 360 is recommended for 3  vagina rejuvenation treatment sessions scheduled once a week.
With either device, a maintenance treatment is recommended every 12 months to maintain and stimulate collagen production levels.

WHAT DOES THE VAGINA REJUVENATION TREATMENT FEELS LIKE? IS IT PAINFUL?

While the ULTRA FEMME 360 and Viveve homogeneously heats the treated area, you will feel a warm pleasant and comfortable heat. Following the vagina rejuvenation treatment, you may notice mild redness and swelling in the treatment area. This usually disappears within a few hours. 

I’m post-menopausal. Will I get relief from my vaginal dryness? 

Laser Vaginal Tightening is an ideal solution for the post-menopausal woman. By promoting collagen production and remodeling in the vagina it results in a return of the rugae (wall folds in vagina) that is sometimes lost with menopause or prolapse. Women report improved lubrication and a decrease in pain associated with penetration. A more youthful vagina is restored.

IS THERE ANY DOWNTIME WITH VAGINA REJUVENATION ULTRA FEMME 360 or Viveve?

There is no downtime. You may resume normal activity immediately afterwards.

HOW FAST WILL I SEE RESULTS?

Some patients notice an improvement after the 1st session. Continual improvement occurs throughout the treatment process.

WHAT MAKES VAGINA REJUVENATION with ULTRA FEMME 360 or Viveve deliver BETTER RESULTS THAN OTHER DEVICES?

We believe both devices deliver optimal results.
The Vagina Rejuvenation ULTRA FEMME 360 can treat both internal and external women’s intimate parts in the same session, in the shortest period of time.
Using radiofrequency waves, the therapy is completely non-invasive and painless.
We recently added the Viveve II laser as it is the next generation powerful non-invasive radiofrequency product for intimate procedures - and it only takes 1 session!
Could your orgasms be better? 
Check out the OStimulation Shot
Read More : Article from Aesthetic News
  • Clinical Study Results with Viveve

    Introduction: Vaginal laxity is a highly prevalent and undertreated medical condition.

    Aim: To evaluate the efficacy and safety of surface-cooled, monopolar radiofrequency (RFc) therapy for the treatment of vaginal laxity in the VIVEVE I trial.

    Methods: The VIVEVE I trial was a prospective, randomized, single-blinded, and sham-controlled study. Nine study centers in Canada, Italy, Spain, and Japan participated. Women presenting with vaginal laxity were screened and informed consent was obtained.Major study inclusion criteria were premenopausal status, age at least 18 years, at least one full-term vaginal delivery, and normal genito-pelvic examination results. Enrolled subjects were randomized (2:1) to receive RFc therapy (Active [90 J/cm2] vs Sham [1 J/cm2], respectively) delivered to the vaginal tissue.

    Main Outcome Measures: The primary efficacy outcome was the proportion of randomized subjects reporting “no vaginal laxity” (Active vs Sham) at 6 months postintervention, which was assessed using the Vaginal Laxity Questionnaire. Treatment-emergent adverse events were evaluated in all treated subjects. Secondary efficacy end points included change on the Female Sexual Function Index (FSFI) and the revised Female Sexual Distress Scale (FSDS-R).


    Results: No vaginal laxity was achieved by 43.5% and 19.6% (P ¼ .002) in the Active and Sham groups, respectively. Differences in FSFI and FSDS-R total scores (Active vs Sham) were 1.8 (P ¼ .031) and “2.42 (P ¼ .056), respectively, in favor of Active treatment. Treatment-emergent adverse events were reported by 11.1% and 12.3% of subjects in the Active and Sham arms, respectively.

    Conclusion: The VIVEVE I trial is the first randomized, controlled, blinded, clinical study of RFc for the treatment of vaginal laxity. A single treatment of RFc therapy was found to be safe and associated with both improved vaginal laxity and improved sexual function. The results from this trial support the use of a novel nonsurgical therapy for vaginal laxity, a prevalent and undertreated condition.


    Krychman M, Rowan CG, Allan BB, et al. Effect of Single-Treatment, Surface-Cooled Radiofrequency Therapy on Vaginal Laxity and Female Sexual Function: The VIVEVE I Randomized Controlled Trial.

    J Sex Med 2017;14:215e225. Copyright 2016, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

I Want to Get Started: Schedule a Consultation for the Exilis or Viveve Vagina Consultation/Treatment